PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON AND RECOMBINANT INTERLEUKIN-2 IN METASTATIC BREAST-CANCER

Authors
WALTERS RS THERIAULT RL HOLMES FA ESPARZA L HORTOBAGYI GN
Citation
Rs. Walters et al., PHASE-II STUDY OF RECOMBINANT ALPHA-INTERFERON AND RECOMBINANT INTERLEUKIN-2 IN METASTATIC BREAST-CANCER, Journal of immunotherapy with emphasis on tumor immunology, 16(4), 1994, pp. 303-305
Citations number
9
Categorie Soggetti
Immunology,Oncology,"Medicine, Research & Experimental
Journal title
Journal of immunotherapy with emphasis on tumor immunology → ACNP
ISSN journal
10675582
Volume
16
Issue
4
Year of publication
1994
Pages
303 - 305
Database
ISI
SICI code
1067-5582(1994)16:4<303:PSORAA>2.0.ZU;2-H
Abstract
Ten patients with metastatic breast cancer were treated with a combina tion of recombinant alpha-interferon and recombinant interleukin-2. Th e toxicity of treatment was considerable, including one death on thera py. No objective responses were seen.